BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 20698856)

  • 21. Sustained administration of trazodone enhances serotonergic neurotransmission: in vivo electrophysiological study in the rat brain.
    Ghanbari R; El Mansari M; Blier P
    J Pharmacol Exp Ther; 2010 Oct; 335(1):197-206. PubMed ID: 20647493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adolescence fluoxetine increases serotonergic activity in the raphe-hippocampus axis and improves depression-like behaviors in female rats that experienced neonatal maternal separation.
    Yoo SB; Kim BT; Kim JY; Ryu V; Kang DW; Lee JH; Jahng JW
    Psychoneuroendocrinology; 2013 Jun; 38(6):777-88. PubMed ID: 23010142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered response to the selective serotonin reuptake inhibitor escitalopram in mice heterozygous for the serotonin transporter: an electrophysiological and neurochemical study.
    Guiard BP; Mansari ME; Murphy DL; Blier P
    Int J Neuropsychopharmacol; 2012 Apr; 15(3):349-61. PubMed ID: 21439106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute and subchronic treatments with selective serotonin reuptake inhibitors increase Nociceptin/Orphanin FQ (NOP) receptor density in the rat dorsal raphe nucleus; interactions between nociceptin/NOP system and serotonin.
    Le Maître E; Dourmap N; Vilpoux C; Leborgne R; Janin F; Bonnet JJ; Costentin J; Leroux-Nicollet I
    Brain Res; 2013 Jul; 1520():51-60. PubMed ID: 23669068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serotonin-1A receptor function in the dorsal raphe nucleus following chronic administration of the selective serotonin reuptake inhibitor sertraline.
    Rossi DV; Burke TF; McCasland M; Hensler JG
    J Neurochem; 2008 May; 105(4):1091-9. PubMed ID: 18182050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. S41744, a dual neurokinin (NK)1 receptor antagonist and serotonin (5-HT) reuptake inhibitor with potential antidepressant properties: a comparison to aprepitant (MK869) and paroxetine.
    Millan MJ; Dekeyne A; Gobert A; Mannoury la Cour C; Brocco M; Rivet JM; Di Cara B; Lejeune F; Cremers TI; Flik G; de Jong TR; Olivier B; de Nanteuil G
    Eur Neuropsychopharmacol; 2010 Sep; 20(9):599-621. PubMed ID: 20483567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The comparative effects of environmental enrichment with exercise and serotonin transporter blockade on serotonergic neurons in the dorsal raphe nucleus.
    MacGillivray L; Reynolds KB; Rosebush PI; Mazurek MF
    Synapse; 2012 May; 66(5):465-70. PubMed ID: 22121041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unchanged density of 5-HT(1A) autoreceptors on the plasma membrane of nucleus raphe dorsalis neurons in rats chronically treated with fluoxetine.
    Riad M; Rbah L; Verdurand M; Aznavour N; Zimmer L; Descarries L
    Neuroscience; 2008 Feb; 151(3):692-700. PubMed ID: 18166275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Escitalopram: a selective inhibitor and allosteric modulator of the serotonin transporter].
    Mnie-Filali O; El Mansari M; Scarna H; Zimmer L; Sánchez C; Haddjeri N
    Encephale; 2007 Dec; 33(6):965-72. PubMed ID: 18789789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Additive effect of rimonabant and citalopram on extracellular serotonin levels monitored with in vivo microdialysis in rat brain.
    Ortega JE; Gonzalez-Lira V; Horrillo I; Herrera-Marschitz M; Callado LF; Meana JJ
    Eur J Pharmacol; 2013 Jun; 709(1-3):13-9. PubMed ID: 23562616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute and chronic effects of citalopram on 5-HT1A receptor-labeling by [18F]MPPF and -coupling to receptors-G proteins.
    Moulin-Sallanon M; Charnay Y; Ginovart N; Perret P; Lanfumey L; Hamon M; Hen R; Fagret D; Ibáñez V; Millet P
    Synapse; 2009 Feb; 63(2):106-16. PubMed ID: 19016488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of 5-HT(1A/1B)-/- mice: an animal model sensitive to anxiolytic treatments.
    Guilloux JP; David DJ; Xia L; Nguyen HT; Rainer Q; Guiard BP; Repérant C; Deltheil T; Toth M; Hen R; Gardier AM
    Neuropharmacology; 2011 Sep; 61(3):478-88. PubMed ID: 21333660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. No effect of C1473G polymorphism in the tryptophan hydroxylase 2 gene on the response of the brain serotonin system to chronic fluoxetine treatment in mice.
    Bazhenova EY; Sinyakova NA; Kulikova EA; Kazarinova IA; Bazovkina DV; Gainetdinov RR; Kulikov AV
    Neurosci Lett; 2017 Jul; 653():264-268. PubMed ID: 28579486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Upregulation of the dorsal raphe nucleus-prefrontal cortex serotonin system by chronic treatment with escitalopram in hyposerotonergic Wistar-Kyoto rats.
    Yamada M; Kawahara Y; Kaneko F; Kishikawa Y; Sotogaku N; Poppinga WJ; Folgering JH; Dremencov E; Kawahara H; Nishi A
    Neuropharmacology; 2013 Sep; 72():169-78. PubMed ID: 23643754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antagonism of 5-HT(1A) receptors uncovers an excitatory effect of SSRIs on 5-HT neuronal activity, an action probably mediated by 5-HT(7) receptors.
    Bosker FJ; Folgering JH; Gladkevich AV; Schmidt A; van der Hart MC; Sprouse J; den Boer JA; Westerink BH; Cremers TI
    J Neurochem; 2009 Mar; 108(5):1126-35. PubMed ID: 19166502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypobaric hypoxia exposure in rats differentially alters antidepressant efficacy of the selective serotonin reuptake inhibitors fluoxetine, paroxetine, escitalopram and sertraline.
    Kanekar S; Sheth CS; Ombach HJ; Olson PR; Bogdanova OV; Petersen M; Renshaw CE; Sung YH; D'Anci KE; Renshaw PF
    Pharmacol Biochem Behav; 2018 Jul; 170():25-35. PubMed ID: 29738811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transgenic elimination of high-affinity antidepressant and cocaine sensitivity in the presynaptic serotonin transporter.
    Thompson BJ; Jessen T; Henry LK; Field JR; Gamble KL; Gresch PJ; Carneiro AM; Horton RE; Chisnell PJ; Belova Y; McMahon DG; Daws LC; Blakely RD
    Proc Natl Acad Sci U S A; 2011 Mar; 108(9):3785-90. PubMed ID: 21282638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A role for serotonin in the antidepressant activity of NG-Nitro-L-arginine, in the rat forced swimming test.
    Gigliucci V; Buckley KN; Nunan J; O'Shea K; Harkin A
    Pharmacol Biochem Behav; 2010 Feb; 94(4):524-33. PubMed ID: 19945477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential modulation of Nav1.7 and Nav1.8 channels by antidepressant drugs.
    Thériault O; Poulin H; Beaulieu JM; Chahine M
    Eur J Pharmacol; 2015 Oct; 764():395-403. PubMed ID: 26187311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of citalopram on serotonin and CRF systems in the midbrain of primates with differences in stress sensitivity.
    Bethea CL; Lima FB; Centeno ML; Weissheimer KV; Senashova O; Reddy AP; Cameron JL
    J Chem Neuroanat; 2011 Jul; 41(4):200-18. PubMed ID: 21683135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.